Year: 2026
Type: erratum
Abstract: The conflict of interest statement was erroneously given as [Author CC was employed by company Merck Serono SpA. The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer AC declared a past co-authorship with the authors MS, RM, and MW to the handling editor.]. The correct conflict of interest statement is [Author CC is employed by company Merck Serono SpA. The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer AC declared a past co-authorship with the authors MS, RM, and MW to the handling editor. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.]. The original version of this article has been updated.
Source: Frontiers in Endocrinology
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7128469571
Cites:
Cited by:
Related to: